Navidea Biopharmaceuticals (NAVB) Short Interest Ratio & Short Volume $0.0005 0.00 (0.00%) As of 08/27/2025 10:36 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Navidea Biopharmaceuticals Short Interest DataNavidea Biopharmaceuticals (NAVB) has a short interest of 400 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 7,543 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.20Short Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares100,080,000 sharesShort Percent of Float0.00%Today's Trading Volume1,075 sharesAverage Trading Volume7,543 sharesToday's Volume Vs. Average14% Short Selling Navidea Biopharmaceuticals? Sign up to receive the latest short interest report for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNAVB Short Interest Over TimeNAVB Days to Cover Over TimeNAVB Percentage of Float Shorted Over Time Navidea Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025400 shares $0.20 No Change0.0%0.1 $0.00 7/15/2025400 shares $0.08 No ChangeN/A0 $0.00 6/30/2025400 shares $0.40 No Change0.0%0.1 $0.00 6/15/2025400 shares $0.28 No Change0.0%0.1 $0.00 5/31/2025400 shares $0.28 No Change0.0%0.4 $0.00 5/15/2025400 shares $0.28 +33.3%N/A0.4 $0.00 4/30/2025300 shares $0.18 -25.0%N/A0 $0.00 4/15/2025400 shares $0.24 No ChangeN/A0.1 $0.00 3/14/2025400 shares $0.04 No ChangeN/A0.2 $0.00 2/14/2025400 shares $0.28 No ChangeN/A0 $0.00 Get the Latest News and Ratings for NAVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025400 shares $0.40 No ChangeN/A0.1 $0.00 1/15/2025400 shares $0.04 No ChangeN/A0 $0.00 6/15/2023570,200 shares $51.32 thousand -35.3%4.5%0.1 $0.09 5/31/2023881,100 shares $81.06 thousand +1,888.9%3.7%0.4 $0.09 5/15/202344,300 shares $0.00 -92.5%0.2%0.1 $0.00 4/30/2023592,800 shares $0.00 +28.7%2.7%4.1 $0.00 4/15/2023460,700 shares $133.05 thousand -7.0%2.1%3.8 $0.29 3/31/2023495,500 shares $0.00 +6.3%2.3%3.7 $0.00 3/15/2023466,100 shares $0.00 +4.2%2.2%3.1 $0.00 2/28/2023447,300 shares $0.00 +2.0%2.1%3 $0.00 2/15/2023438,500 shares $0.00 +38.2%2.1%2.9 $0.00 1/31/2023317,300 shares $0.00 +660.9%1.5%2.3 $0.00 1/15/202341,700 shares $0.00 +118.3%0.2%0.4 $0.00 12/30/202219,100 shares $0.00 -83.7%0.1%0.2 $0.00 12/15/2022117,200 shares $0.00 -12.5%0.5%1.7 $0.00 11/30/2022133,900 shares $0.00 +27.5%0.6%1.3 $0.00 11/15/2022105,000 shares $0.00 -8.2%0.5%0.8 $0.00 10/31/2022114,400 shares $0.00 -50.2%0.5%0.7 $0.00 10/15/2022229,900 shares $0.00 -50.7%1.1%1.4 $0.00 9/30/2022466,700 shares $0.00 +20.2%2.2%3 $0.00 9/15/2022388,300 shares $0.00 +60.3%1.8%2.6 $0.00 8/31/2022242,300 shares $0.00 +319.9%1.1%2.3 $0.00 8/15/202257,700 shares $0.00 -2.9%0.3%0.9 $0.00 7/31/202259,400 shares $0.00 -38.1%0.3%1.4 $0.00 7/15/202296,000 shares $0.00 -5.0%0.4%1.9 $0.00 6/30/2022101,000 shares $0.00 +45.3%0.5%0.3 $0.00 6/15/202269,500 shares $0.00 -16.3%N/A0.2 $0.00 5/31/202283,000 shares $0.00 +2.1%0.4%0.2 $0.00 5/15/202281,300 shares $0.00 -63.6%0.4%0.2 $0.00 4/30/2022223,300 shares $0.00 +121.5%1.0%0.6 $0.00Small Washington, DC Group Could Crash US Stocks (Ad)New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008."Click here for full details while you still have time to move your money. 4/15/2022100,800 shares $0.00 -1.0%0.5%0.3 $0.00 3/31/2022101,800 shares $0.00 -33.4%0.5%1.6 $0.00 3/15/2022152,800 shares $0.00 -15.9%0.7%2.1 $0.00 2/28/2022181,600 shares $0.00 -7.6%0.8%2.2 $0.00 2/15/2022196,500 shares $0.00 -12.4%0.9%2.3 $0.00 1/31/2022224,400 shares $0.00 -1.4%1.0%2.4 $0.00 1/15/2022227,500 shares $0.00 +1.9%1.1%3.3 $0.00 12/31/2021223,200 shares $0.00 +63.9%1.0%3.1 $0.00 12/15/2021136,200 shares $0.00 -7.1%0.6%2.1 $0.00 11/30/2021146,600 shares $0.00 +4.1%0.7%2.3 $0.00 11/15/2021140,900 shares $0.00 -10.8%0.6%2.4 $0.00 10/29/2021157,900 shares $0.00 -9.3%0.7%2.9 $0.00 10/15/2021174,100 shares $0.00 -7.0%0.8%4 $0.00 9/30/2021187,200 shares $0.00 +13.8%0.9%3 $0.00 9/15/2021164,500 shares $0.00 -5.4%0.8%2.5 $0.00 8/31/2021173,800 shares $0.00 +9.3%0.8%2.4 $0.00 8/13/2021159,000 shares $0.00 -17.0%0.7%1.4 $0.00 7/30/2021191,500 shares $0.00 -4.3%0.9%1.5 $0.00 7/15/2021200,000 shares $0.00 -1.6%1.0%1.4 $0.00 6/30/2021203,200 shares $0.00 +12.3%1.0%1.4 $0.00 6/15/2021181,000 shares $0.00 +30.2%0.9%0.9 $0.00 5/28/2021139,000 shares $0.00 -23.4%0.7%0.7 $0.00 5/14/2021181,500 shares $0.00 +5.5%N/A0.8 $0.00 4/30/2021172,000 shares $0.00 -7.2%N/A0.6 $0.00 4/15/2021185,300 shares $290.92 thousand -15.5%N/A0.5 $1.57 3/31/2021219,400 shares $355.43 thousand +49.3%N/A0.6 $1.62 3/15/2021147,000 shares $255.78 thousand -22.3%N/A0.4 $1.74 2/26/2021189,200 shares $389.75 thousand +13.8%N/A0.6 $2.06 2/12/2021166,200 shares $402.20 thousand -33.0%N/A0.5 $2.42 1/29/2021248,100 shares $615.29 thousand -8.4%N/A0.6 $2.48 1/15/2021270,800 shares $785.32 thousand -2.9%N/A0.9 $2.90 12/31/2020279,000 shares $558 thousand -1.6%N/A1.1 $2.00 12/15/2020283,500 shares $532.98 thousand +9.0%N/A1.2 $1.88 11/30/2020260,000 shares $624 thousand +32.9%N/A1.1 $2.40 11/15/2020195,600 shares $539.86 thousand +3.4%N/A0.8 $2.76 10/30/2020189,100 shares $457.62 thousand -3.3%N/A1.1 $2.42 10/15/2020195,600 shares $535.94 thousand -11.1%N/A0.8 $2.74 9/30/2020220,100 shares $594.27 thousand +11.4%N/A0.7 $2.70 9/15/2020197,500 shares $582.63 thousand -12.7%1.1%0.6 $2.95 8/31/2020226,100 shares $671.52 thousand +5.0%1.3%0.5 $2.97 NAVB Short Interest - Frequently Asked Questions What is Navidea Biopharmaceuticals' current short interest? Short interest is the volume of Navidea Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 400 shares of NAVB short. 0.00% of Navidea Biopharmaceuticals' shares are currently sold short. Learn More on Navidea Biopharmaceuticals' current short interest. What is a good short interest percentage for Navidea Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Navidea Biopharmaceuticals' floating shares are currently sold short. How does Navidea Biopharmaceuticals' short interest compare to its competitors? 0.00% of Navidea Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Navidea Biopharmaceuticals: Smart for Life, Inc. (0.01%), Virpax Pharmaceuticals, Inc. (0.25%), Scopus BioPharma Inc. (0.03%), Aridis Pharmaceuticals, Inc. (0.05%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), PaxMedica, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Navidea Biopharmaceuticals stock? Short selling NAVB is an investing strategy that aims to generate trading profit from Navidea Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Navidea Biopharmaceuticals? A short squeeze for Navidea Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NAVB, which in turn drives the price of the stock up even further. How often is Navidea Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAVB, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies SMFL Short Interest VRPX Short Interest SCPS Short Interest ARDS Short Interest EVLO Short Interest CMRA Short Interest GNCAQ Short Interest STAB Short Interest AMPE Short Interest PXMD Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NAVB) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access